A Novel Prognostic Model in Heavily Treated Patients with Myelodysplastic Syndromes (MDS)

被引：0
|
作者：
Nazha, Aziz [1 ]
Seastone, David J. [1 ]
Radivoyevitch, Tomas [1 ]
Gerds, Aaron T. [1 ]
Mukherjee, Sudipto [1 ]
Carraway, Hetty E. [1 ]
Advani, Anjali S. [1 ]
Kalaycio, Matt E. [1 ]
Rupp, Gina [1 ]
Colaluka, Kristin [1 ]
Hobson, Sean [1 ]
Maciejewski, Jaroslaw P. [1 ]
Sekeres, Mikkael A. [1 ]
机构：
[1] Cleveland Clin, Cleveland, OH 44106 USA
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Rigosertib in myelodysplastic syndromes (MDS)
    Raza, A.
    Ali, A. M.
    Reddy, M. V. R.
    Hoffman, B. S.
    Petrone, M. E.
    Maniar, M.
    Pinheiro, R. F.
    Coutinho, D. F.
    Fruchtman, S. M.
    EXPERT OPINION ON ORPHAN DRUGS, 2016, 4 (09): : 981 - 988
  • [32] Update on myelodysplastic syndromes (MDS)
    Hector Rodriguez, Jose
    del Lujan Acosta, Irma
    REVISTA MEDICA DE ROSARIO, 2011, 77 (01): : 24 - 41
  • [33] Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS)
    Yao, Chi-Yuan
    Hou, Hsin-An
    Lin, Tzung-Yi
    Lin, Chien-Chin
    Chou, Wen-Chien
    Tseng, Mei-Hsuan
    Chiang, Ying-Chieh
    Liu, Ming-Chih
    Liu, Chia-Wen
    Kuo, Yuan-Yeh
    Wu, Shang-Ju
    Liao, Xiu-Wen
    Lin, Chien-Ting
    Ko, Bor-Shen
    Chen, Chien-Yuan
    Hsu, Szu-Chun
    Li, Chi-Cheng
    Huang, Shang-Yi
    Yao, Ming
    Tang, Jih-Luh
    Tsay, Woei
    Liu, Chieh-Yu
    Tien, Hwei-Fang
    ONCOTARGET, 2016, 7 (39) : 63177 - 63188
  • [34] Validation of the Lower Risk MD Anderson Prognostic Scoring System for Patients with Myelodysplastic Syndromes (MDS)
    Ramadan, Hanadi
    Corrales-Yepez, Maria
    Ali, Najla
    Zhang, Ling
    Padron, Eric
    Lancet, Jeffrey
    List, Alan
    Komrokji, Rami
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 : S232 - S233
  • [35] The pathogenesis of myelodysplastic syndromes (MDS)
    Platzbecker, Uwe
    Meredyth-Stewart, Michelle
    Ehninger, Gerhard
    CANCER TREATMENT REVIEWS, 2007, 33 : S53 - S58
  • [36] Serum cytokine levels in patients with myelodysplastic syndromes (MDS).
    Allampallam, K
    Shetty, V
    Mundle, S
    Dutt, D
    Reddy, PL
    Alvi, S
    Galili, N
    Saberwal, GS
    Anthwal, S
    Shaikh, MW
    York, A
    Gezer, S
    Venugopal, P
    Raza, A
    BLOOD, 2001, 98 (11) : 269B - 270B
  • [37] Myelodysplastic syndromes (MDS) Preface
    Klimek, Virginia
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2015, 28 (01) : 1 - 2
  • [38] CHROMOSOMAL RESULTS IN 50 PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS)
    LESSARD, M
    BRIZARD, A
    GUILHOT, F
    TANZER, J
    BLUT, 1988, 56 (06): : C9 - C9
  • [39] International prognostic scoring system (IPSS) and other prognostic systems for myelodysplastic syndromes (MDS).
    Balduini, CL
    Guarnone, R
    Pecci, A
    Centenara, E
    BLOOD, 1997, 90 (10) : 4026 - 4026
  • [40] Incorporation of Molecular Data into the Current Prognostic Models in Treated Patients with Myelodysplastic Syndromes: Which Model Is the Best
    Al-Issa, Karam
    Zarzour, Ahmad
    Radivoyevitch, Tomas
    Kalaycio, Matt
    Hamilton, Betty K.
    Gerds, Aaron T.
    Mukherjee, Sudipto
    Adema, Vera
    Clemente, Michael J.
    Patel, Bhumika
    Hirsch, Cassandra M.
    Advani, Anjali S.
    Przychodzen, Bartlomiej P.
    Carraway, Hetty E.
    Maciejewski, Jaroslaw P.
    Sekeres, Mikkael A.
    Nazha, Aziz
    BLOOD, 2016, 128 (22)
12345